Cyclooxygenase-2 expression in dermatofibroma and dermatofibrosarcoma protuberans

Journal of Cutaneous Pathology

Volumn 35, Issue 6, 2008, Pages 532-535

  Adler, Neta ^a   Tsabari, Cochava ^a   Sulkes, Jaqueline ^a,b   Ad El, Dean ^a   Feinmesser, Meora ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; ENZYME ANTIBODY; FORMALDEHYDE; PARAFFIN;

ARTICLE; CANCER GRADING; CANCER TISSUE; CONTROLLED STUDY; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

CYCLOOXYGENASE 2; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 43349095499     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2007.00855.x     Document Type: Article

References (18)

1. Vanni R, Fletcher CD, Sciot R, et al. Cytogenetic evidence of clonality in cutaneous benign fibrous histiocytomas: a report of the CHAMP study group. Histopathology 2000 37 : 212.
2. Shea CH, Prieto VG. Fibrous lesions in dermis and soft tissue. In Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Fitzpatrick's dermatology in general medicine, 6th ed., Vol. 1. New York : McGraw-Hill, Medical Publishing Division, 2003 995 997.
3. Li N, McNiff J, Hui P, Manfioletti G, Tallini G. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity. Am J Dermatopathol 2004 26 : 267.
4. Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol 1993 28 : 613.
5. Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 1993 15 : 429.
6. Cohen PR, Rapini RP, Farhood AI. Dermatofibroma and dermatofibrosarcoma protuberans: differential expression of CD34 and factor XIIIa. Am J Dermatopathol 1994 16 : 573.
7. Hsi ED, Nickoloff BJ. Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles. J Dermatol Sci 1996 11 : 1.
8. Kahn HJ, Fekete E, From L. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa. Hum Pathol 2001 32 : 50.
9. Cribier B, Noacco G, Peltre B, Grosshans E. Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans. J Am Acad Dermatol 2002 46 : 408.
10. Calikoglu E, Augsburger E, Chavaz P, Saurat JH, Kaya G. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. J Cutan Pathol 2003 30 : 185.
11. Brune K, Hinz B. Selective cyclooxygenase-2 inhibitors: similarities and differences. Scand J Rheumatol 2004 33 : 1.
12. Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB, De Marzo AM. Cyclooxygenases in cancer: progress and perspective. Cancer Lett 2004 215 : 1.
13. Gately S, Li WW. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Sem Oncol 2004 31 (Suppl. 7 2.
14. Kasamaki S, Suda K, Kamino T, Kumasaka T, Ochiai T, Haraguchi Y. COX-2+ myofibroblasts may play a key role in marked stromal fibrosis in strictured colorectal carcinoma. Histopathology 2004 44 : 445.
15. Wendum D, Comperat E, Boelle PY, et al. Cytoplasmic phospholipase A2 alpha overexpression in stromal cells is correlated with angiogenesis in human colorectal cancer. Mod Pathol 2005 18 : 212.
16. Adegboyega PA, Ololade O, Saada J, Mifflin R, Di Mari JF, Powell DW. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas. Clin Cancer Res 2004 10 : 5870.
17. Gasparini G, Longo R, Sarmiento R, Morabito A. Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol 2003 4 : 605.
18. Mckee PH, Calonje E, Granter SR. Connective tissue tumors. In Mckee PH, Calonje E, Granter SR, eds. Pathology of the skin, 3rd ed. Boston : Mosby, 2005 1744.